Abstract
The selective loss of neurones in a range of neurodegenerative diseases is widely thought to involve the process of excitotoxicity, in which glutamate-mediated neuronal killing is elaborated through the excessive stimulation of cell-surface receptors. Every such disease exhibits a distinct regional and subregional pattern of neuronal loss, so processes must be locally triggered to different extents to account for this. We have studied several mechanisms which could lead to excitotoxic glutamate pathophysiology and compared them indifferent diseases. Our data suggest that glutamate can reach toxic extracellular levels in Alzheimer disease by malfunctions in cellular transporters, and that the toxicity may be exacerbated by continued glutamatere lease from presynaptic neurones acting on hypersensitive postsynaptic receptors. Thus the excitotoxicity is direct. In contrast, alcoholic brain damage arises in regions where GABA-mediated inhibition is deficient, and fails properly to dampen trans-synaptic excitation. Thus the excitotoxicity is indirect. A variety of such mechanisms is possible, which may combine in different ways.
Similar content being viewed by others
References
Albin RL and Greenamyre JT (1992) Alternative excitotoxic hypotheses. Neurology 42: 733-738
Arriza JL, Eliasof S, Kavanaugh MP and Amara SG (1997) Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc Natl Acad Sci USA 94: 4155-4160
Balcar VJ and Li Y (1992) Heterogeneity of high affinity uptake of L-glutamate and L-aspartate in the mammalian central nervous system. Life Sci 51: 1467-1478
Blakely RD, Clark JA, Pacholczyk T and Amara SG (1991) Distinct, developmentally regulated brain mRNAs direct the synthesis of neurotransmitter transporters. J Neurochem 56: 860-871
Bradford HF and Dodd PR (1976a) Biochemistry and basic mechanisms in epilepsy. In: Davison AN (ed) Biochemistry and Neurological Disease, pp 114-167. Blackwell, London
Bradford HF and Dodd PR (1976b) Convulsions and activation of epileptic foci induced by monosodium glutamate and related compounds. Biochem Pharmacol 26: 253-254
Buckley ST, Eckert AL and Dodd PR (2000) Expression and distribution of GABAA receptor subtypes in human alcoholic brain. Ann NY Acad Sci 914: 58-64
Butterworth RF, Lavoie J, Giguère JF, Pomier-Layrargues G and Bergeron M (1987) Cerebral GABA-ergic and glutamatergic function in hepatic encephalopathy. Neurochem Pathol 6: 131-144
Chapman AG (2000) Glutamate and epilepsy. J Nutr 130: 1043S-1045S
Chapman AG, Durmuller N, Lees GJ and Meldrum BS (1989) Excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres. Neurosci Lett 107: 256-260
Collingridge GL and Lester RAJ (1989) Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol Rev 40: 143-210
Dehnes Y, Chaudhry FA, Ullensvang K, Lehre KP, Storm-Mathisen J and Danbolt NC (1998) The glutamate transporter EAAT4 in rat cerebellar Purkinje cells: a glutamate-gated chloride channel concentrated near the synapse in parts of the dendritic membrane facing astroglia. J Neurosci 18: 3606-3619
Dodd PR, Hambley JW, Cowburn RF and Hardy JA (1988) A comparison of methodologies for the study of functional transmitter neurochemistry in human brain. J Neurochem 50: 1333-1345
Dodd PR, Thomas GJ, Harper CG and Kril JJ (1992) Amino acid neurotransmitter receptor changes in cerebral cortex in alcoholism: effect of cirrhosis of the liver. J Neurochem 59: 1506-1515
Dodd PR, Scott HL and Westphalen RI (1994) Excitotoxic mechanisms in the pathogenesis of dementia. Neurochem Internat 25: 203-219
Dodd PR, Kril JJ, Thomas GJ, Watson WEJ, Johnston GAR and Harper CG (1996) Receptor binding sites and uptake activities mediating GABA neurotransmission in chronic alcoholics with Wernicke encephalopathy. Brain Res 710: 215-228
Dodd PR and Lewohl JM (1998) Cell death mediated by amino acid transmitter receptors in human alcoholic brain damage: conflicts in the evidence. Ann NY Acad Sci 844: 50-58
Dodd PR, Beckmann AM, Davidson MS and Wilce PA (2000) Glutamate-mediated transmission, alcohol, and alcoholism. Neurochem Internat 37: 509-533
Duncan GE, Breese GR, Criswell HE, McCown TJ, Herbert JS, Devaud LL and Morrow AL (1995) Distribution of [3H]zolpidem binding sites in relation to messenger RNA encoding the ?1, ?2 and ?2 subunits of GABAA receptors in rat brain. Neuroscience 64: 1113-1128
Eisen AA (1995) Amyotrophic lateral sclerosis is a multifactorial disease. Muscle Nerve 18: 741-752
Gilman SC, Bonner MJ and Pellmar TC (1994) Free radicals enhance basal release of D-[3H]aspartate from cerebral cortical synaptosomes. J Neurochem 62: 1757-1763
Gruen RJ, Elsworth JD and Roth RH (1990) Regionally specific alterations in the low-affinity GABAA receptor following exposure to diazepam. Brain Res 514: 151-154
Hardy JA, Cowburn RF, Barton A, Reynolds GP, Lofdahl E, O'Carroll A-M, Wester P and Winblad B (1987) Region-specific loss of glutamate innervation in Alzheimer's disease. Neurosci Lett 73: 77-80
Haugeto O, Ullensvang K, Levy LM, Chaudhry FA, Honore T, Nielsen M, Lehre KP and Danbolt NC (1996) Brain glutamate transporter proteins form homomultimers. J Biol Chem 271: 27715-27722
Hornung J-P and de Tribolet N (1994) Distribution of GABAcontaining neurons in human frontal cortex: a quantitative immunocytochemical study. Anat Embryol (Berlin) 189: 139-145
Hume Adams J, Corsellis JAN and Duchen LW(1984) Greenfield's Neuropathology, 4th ed, pp 726-733, 971-980. Wiley-Medical, New York
Hyman BT, van Hoesen GW, Damasio AR and Barnes CL (1984) Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 225: 1168-1170
Hynd M, Scott HL and Dodd PR (2001) GlutamateNMDA receptor NR1 subunit mRNA expression in Alzheimer's disease. J Neurochem 78: 175-182
Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42: 1097-1105
Kril JJ, Halliday GM, Svoboda MD and Cartwright H (1997) The cerebral cortex is damaged in chronic alcoholics. Neuroscience 79: 983-998
Lavoie J, Giguère JF, Pomier-Layrargues G and Butterworth RF (1987) Activities of neuronal and astrocytic marker enzymes in autopsied brain tissue from patients with hepatic encephalopathy. Metab Brain Dis 2: 283-290
Lewohl JM, Crane DI and Dodd PR (1997a) Expression of the ?1, ?2 and ?3 isoforms of the GABAA receptor in human alcoholic brain. Brain Res 751: 102-112
Lewohl JM, Crane DI and Dodd PR (1997b) Zolpidem binding sites on the GABAA receptor in brain from human cirrhotic and noncirrhotic alcoholics. Eur J Pharmacol 326: 265-272
Lewohl JM, Huygens F, Crane DI and Dodd PR (2001) GABAA receptor ? subunit proteins in human chronic alcoholics. J Neurochem 78: 424-434
Lustig HS, von Brauchitsch KL, Chan J and Greenberg DA (1992) A novel inhibitor of glutamate release reduces excitotoxic injury in vitro. Neurosci Lett 143: 229-232
Mattson MP, Cheng B, Davis DL, Bryant K, Lieberburg I and Rydel RE (1992) ?-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12: 376-389
Meyer T, Munch C, Knappenberger B, Liebau S, Volkel H and Ludolph AC (1998) Alternative splicing of the glutamate transporter EAAT2 (GLT-1). Neurosci Lett 241: 68-70
Miller S, Kesslak JP, Romano C and Cotman CW (1995) Roles of metabotropic glutamate receptors in brain plasticity and pathology. Ann NY Acad Sci 757: 460-474
Mortensen M and Dodd PR (1999) The modulatory effect of spermine on the glutamate-NMDA receptor is regionally variable in normal human adult cerebral cortex. Pharmacol Toxicol 84: 135-142
Naskar R, Vorwerk CK and Dreyer EB (2000) Concurrent downregulation of a glutamate transporter and receptor in glaucoma. Invest Ophthalmol Vis Sci 41: 1940-1944
Nielsen KJ, Skjærbæk N, Dooley M, Adams DA, Mortensen M, Dodd PR, Craik DJ, Alewood PF and Lewis RJ (1999) Stuctureactivity relationships of conantokins at the human glutamate-NMDA receptor. J Med Chem 42: 415-426
Ogata T, Nakamura Y, Shibata T and Kataoka K (1992) Release of excitatory amino acids from cultured hippocampal astrocytes induced by a hypoxic-hypoglycemic stimulation. J Neurochem 58: 1957-1959
Ozkan ED and Ueda T (1998) Glutamate transport and storage in synaptic vesicles. Jpn J Pharmacol 77: 1-10
Poli A, Contestabile A, Migani P, Rossi L, Rondelli C, Virgili M, Bissoli R and Barnabei O (1985) Kainic acid differentially affects the synaptosomal release of endogenous and exogenous amino acidic neurotransmitters. J Neurochem 45: 1677-1686
Pritchett DB, Lüddens H and Seeburg PH (1989) Type I and type II GABAA-benzodiazepine receptors produced in transfected cells. Science 245: 1389-1391
Rothman SM and Olney JW (1986) Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19: 105-111
Rothstein JD, Martin LJ and Kuncl RW(1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 326: 1464-1468
Rothstein JD, Martin LJ, Levey AI, Dykes-Hoberg M, Jin L, Wu D, Nash N and Kuncl RW (1994) Localization of neuronal and glial glutamate transporters. Neuron 13: 713-725
Rothstein JD, van Kammen M, Levey AI, Martin LJ and Kuncl RW (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38: 73-84
Schoepp DD, Johnson BG, Salhoff CR, McDonald JW and Johnston MV (1991) In vitro and in vivo pharmacology of transand cis-(+-)-1-amino-1,3-cyclopentanedicarboxylic acid: dissociation of metabotropic and ionotropic excitatory amino acid receptor effects. J Neurochem 56: 1789-1796
Scott HL, Tannenberg AEG and Dodd PR (1995) Variant forms of neuronal glutamate transporter sites in Alzheimer's disease cerebral cortex. J Neurochem 64: 2193-2202
Scott HL, Tannenberg RK, Westphalen RI and Dodd PR (2002a) The identification and characterization of excitotoxic nerveendings in Alzheimer disease. Neuromol Med (in press)
Scott HL, Tannenberg AEG, Pow DA and Dodd PR (2002b) Aberrant expression of glutamate transporter EAATI in Alzheimer's disease. J Neurosci (in press)
Seeburg PH (1990) Elucidating GABAA receptor heterogeneity: an integrated molecular approach. In: Biggio G and Costa E (eds) GABA and Benzodiazepine Receptor Subtypes, pp 15-21. Raven Press, New York
Sladeczek F, Manzoni O, Fagni L, Dumuis A, Pin J-P, Sebben M and Bockaert J (1992) The metabotropic glutamate receptor (MGR): pharmacology and subcellular location. J Physiol (Paris) 86: 47-55
Thomas RJ (1995) Excitatory amino acids in health and disease. J Amer Geriatr Soc 43: 1279-1289
Uldall P, Hansen FJ and Tonnby B (1993) Lamotrigine in Rett syndrome. Neuropediatrics 24: 339-340
Yao H, Ooboshi H, Ibayashi S, Uchimura H and Fujishima M (1993) Cerebral blood flow and ischemia-induced neurotransmitter release in the striatum of aged spontaneously hypertensive rats. Stroke 24: 577-580
Yoshioka A, Hardy M, Younkin DP, Grinspan JB, Stern JL and Pleasure D (1995) ?-Amino-3-hydroxy-5-methyl-4-isoxazolepro pionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage. J Neurochem 64: 2442-2448
Zeevalk GD, Hyndman AG and Nicklas WJ (1989) Excitatory amino acid-induced toxicity in chick retina: amino acid release, histology, and effects of chloride channel blockers. J Neurochem 53: 1610-1619
Zeevalk GD, Schoepp DD and Nicklas WJ (1995) Excitotoxicity at both NMDA and non-NMDA glutamate receptors is antagonized by aurintricarboxylic acid: evidence for differing mechanisms of action. J Neurochem 64: 1749-1758
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dodd, P.R. Excited to death: different ways to lose your neurones. Biogerontology 3, 51–56 (2002). https://doi.org/10.1023/A:1015255312948
Issue Date:
DOI: https://doi.org/10.1023/A:1015255312948